Head-to-head · Cost-Efficiency Index
CoreAge Rx vs MEDGm
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxMEDGm
Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Visit MEDGmThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 60. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. MEDGm still earns a C — Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | MEDGm |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 60/100 |
| Semaglutide / mo | $99/mo | $299/mo month-to-month (the advertised $179 is the first month only, after an automatically applied coupon) |
| Tirzepatide / mo | $149/mo | $399/mo month-to-month (the advertised $279 is the first month only) |
| Semaglutide / yr (modeled) | $1,188 | $3,588 |
| Tirzepatide / yr (modeled) | $1,788 | $4,788 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #193 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 371 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
MEDGm
60/100Where the value is
- Names all four pharmacy partners in its terms, with street addresses, phone numbers and websites, and says which compounding classes they operate under
- Names seven prescribing professional corporations on its consent page rather than referring to an unnamed medical group
- Publishes the full ladder for three GLP-1 routes — injection, oral tablet and tirzepatide — at one, three, six and twelve months
The tradeoffs
- "Starting at $179" is a first-month rate produced by an automatically applied coupon; the standing month-to-month price is $299, and the same shape applies to the oral tablet and to tirzepatide
- The treatments FAQ says "your price never increases" on a plan whose price increases by $120 at the first renewal
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.